`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`APOTEX CORP.,
`Petitioner
`
`v.
`
`ALCON RESEARCH, LTD.,
`Patent Owner.
`
`
`Case IPR2013-00428
`U.S. Patent No. 8,268,299 B2
`
`
`
`
`
`
`
`
`
`
`
`ALCON RESEARCH, LTD.’S MOTION FOR
`PRO HAC VICE ADMISSION OF CHRISTOPHER J. MANDERNACH
`PURSUANT TO 37 C.F.R. § 42.10(c)
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case IPR2013-00428
`U.S. Patent No. 8,268,299
`I.
`RELIEF REQUESTED
`
`
`
`
`Attorney Docket No.
`PAT903205-US-NP
`
`Pursuant to 37 C.F.R. § 42.10(c), the Board’s Notice of Filing Date
`
`Accorded to Petition and Time for Filing Patent Order Preliminary Response
`
`(Paper 4, dated July 10, 2013) (hereinafter “Authorizing Order”), and the Board’s
`
`“Order–Authorizing Motion for Pro Hac Vice Admission” in Case IPR2013-00639
`
`(hereinafter “Unified Patents Order”), Patent Owner Alcon Research, Ltd.
`
`(“Alcon”) respectfully requests pro hac vice admission of Christopher J.
`
`Mandernach in this proceeding. Petitioner Apotex Corp. does not object to the
`
`relief requested herein.
`
`II. GOVERNING LAW, RULES, AND PRECEDENT
`
`The Board is authorized to recognize counsel pro hac vice pursuant to 37
`
`C.F.R. § 42.10(c), which provides that:
`
`The Board may recognize counsel pro hac vice during a proceeding
`upon a showing of good cause, subject to the condition that lead
`counsel be a registered practitioner and to any other conditions as the
`Board may impose. For example, where the lead counsel is a
`registered practitioner, a motion to appear pro hac vice by counsel
`who is not a registered practitioner may be granted upon showing that
`counsel is an experienced litigating attorney and has an established
`familiarity with the subject matter at issue in the proceeding.
`
`
`
`The Authorizing Order requires that any motion for pro hac vice admission
`
`be filed in accordance with the “Order – Authorizing Motion for Pro Hac Vice
`
`
`
`1
`
`
`
`Attorney Docket No.
`
`Case IPR2013-00428
`PAT903205-US-NP
`
`U.S. Patent No. 8,268,299
`Admission” in Case IPR 2013-00010 (MPT) (“Prior Order”). See Authorizing
`
`Order at 2. However, the Prior Order was issued prior to publication of the Final
`
`Rule adopting new Rules of Professional Conduct. See Changes to Representation
`
`of Others Before the United States Patent and Trademark Office; Final Rule, 78
`
`Fed. Reg. 20,180 (Apr. 3, 2013); see also Unified Patents Order at 2. The Final
`
`Rule removes part 10 of title 37, Code of Federal Regulations (C.F.R.), referred to
`
`in the Prior Order. See Unified Patents Order at 2. As a result, the Board has
`
`determined that its Unified Patents Order “updates and supersedes” the Prior
`
`Order. Unified Patents Order at 2. Accordingly, Alcon assumes that the Board
`
`wishes counsel to follow as a representative order the Unified Patents Order and
`
`has done so in this motion.
`
`The Unified Patents Order requires that a pro hac vice motion “[c]ontain a
`
`statement of facts showing there is good cause for the Board to recognize counsel
`
`pro hac vice during the proceeding.” Unified Patents Order at 3. A motion for pro
`
`hac vice admission should also be accompanied by an affidavit or declaration of
`
`the individuals seeking to appear attesting to the following:
`
`i.
`
`Membership in good standing of the Bar of at least one State or the
`
`District of Columbia;
`
`ii.
`
`No suspensions or disbarments from practice before any court or
`
`administrative body;
`
`
`
`2
`
`
`
`Attorney Docket No.
`
`Case IPR2013-00428
`PAT903205-US-NP
`
`U.S. Patent No. 8,268,299
`iii. No application for admission to practice before any court or
`
`administrative body ever denied;
`
`iv. No sanctions or contempt citations imposed by any court or
`
`administrative body;
`
`v.
`
`The individual seeking to appear has read and will comply with the
`
`Office Patent Trial Practice Guide and the Board’s Rules of Practice
`
`for Trials set forth in part 42 of 37 C.F.R.;
`
`vi.
`
`The individual will be subject to the USPTO Rules of Professional
`
`Conduct set forth in 37 C.F.R. §§ 11.101 et seq. and disciplinary
`
`jurisdiction under 37 C.F.R. § 11.19(a);
`
`vii. All other proceedings before the Office for which the individual has
`
`applied to appear pro hac vice in the last three (3) years; and
`
`viii. Familiarity with the subject matter at issue in the proceeding.
`
`Unified Patents Order at 3–4.
`
`
`
`In its Authorizing Order, the Board gave Alcon permission to file motions
`
`for pro hac vice admission. (See Paper 4 at 2.) Pursuant to that Order, Alcon
`
`hereby files a motion for pro hac vice admission of Christopher J. Mandernach.
`
`
`
`3
`
`
`
`Case IPR2013-00428
`U.S. Patent No. 8,268,299
`III. STATEMENT OF FACTS
`
`
`
`
`Attorney Docket No.
`PAT903205-US-NP
`
`Based on the following facts, and supported by the Declaration of Mr.
`
`Mandernach (AL 2075) submitted herewith, Alcon requests the pro hac vice
`
`admission of Christopher J. Mandernach in this proceeding:
`
`1.
`
`Alcon’s lead counsel, Stanley E. Fisher, and back-up counsel, David
`
`M. Krinsky and Barry L. Copeland, are registered practitioners
`
`(Fisher, Reg. No. 55,820); (Copeland, Reg. No. 34,801); (Krinsky,
`
`Reg. No. 72,339).
`
`2. Mr. Mandernach has established familiarity with the subject matter at
`
`issue in this proceeding. As detailed below, Mr. Mandernach is trial
`
`counsel to Alcon in various related proceedings in which the claims of
`
`the ’299 patent are at issue. (AL 2075 ¶ 10.) Mr. Mandernach has
`
`worked directly with Alcon’s expert witnesses on the matters at issue
`
`in this proceeding. (Id.)
`
`3. Mr. Mandernach is a member in good standing of the bars of the State
`
`of Minnesota and the District of Columbia. (AL 2075 ¶ 3.)
`
`4. Mr. Mandernach has never been suspended or disbarred from practice
`
`before any court or administrative body. (AL 2075 ¶ 4.)
`
`5.
`
`No court or administrative body has ever denied Mr. Mandernach’s
`
`application for admission to practice before it. (AL 2075 ¶ 5.)
`
`
`
`4
`
`
`
`Attorney Docket No.
`
`Case IPR2013-00428
`PAT903205-US-NP
`
`U.S. Patent No. 8,268,299
`6.
`No court or administrative body has ever imposed sanctions or
`
`contempt citations on Mr. Mandernach. (AL 2075 ¶ 6.)
`
`7. Mr. Mandernach has read and will comply with the Office of Patent
`
`Trial Practice Guide and the Board’s Rules of Practice for Trials set
`
`forth in part 42 of 37 C.F.R. (AL 2075 ¶ 7.)
`
`8. Mr. Mandernach understands that he will be subject to the USPTO
`
`Code of Professional Responsibility set forth in 37 C.F.R. §§ 11.101
`
`et seq. and will be subject to disciplinary jurisdiction under 37 C.F.R.
`
`§ 11.19(a). (AL 2075 ¶ 8.)
`
`9. Mr. Mandernach is concurrently seeking pro hac vice admission to
`
`appear in the Petitioner’s inter partes challenges to U.S. Patent Nos.
`
`8,323,630 and 8,388,941. Those proceedings have been designated
`
`IPR2013-00429 and IPR2013-00430, respectively. Mr. Mandernach
`
`has not applied to appear pro hac vice in any other proceedings before
`
`the Office in the last three (3) years. (AL 2075 ¶ 9.)
`
`IV. GOOD CAUSE EXISTS FOR THE PRO HAC VICE ADMISSION OF
`MR. MANDERNACH IN THIS PROCEEDING.
`
`The Board may recognize counsel pro hac vice during a proceeding upon a
`
`showing of good cause, subject to the condition that lead counsel be a registered
`
`practitioner and to any other conditions as the Board may impose. 37 C.F.R.
`
`§ 42.10(c). Alcon’s lead counsel, Stanley E. Fisher, and back-up counsel, David
`5
`
`
`
`
`
`Attorney Docket No.
`
`Case IPR2013-00428
`PAT903205-US-NP
`
`U.S. Patent No. 8,268,299
`M. Krinsky and Barry L. Copeland, are registered practitioners before the Board.
`
`Based on the facts contained herein, as supported by Mr. Mandernach’s
`
`declaration, good cause exists to admit Mr. Mandernach pro hac vice in this
`
`proceeding.
`
`As set forth in his declaration, Mr. Mandernach has established familiarity
`
`with the subject matter at issue in the proceeding. Mr. Mandernach represents
`
`Alcon in federal district court litigation concerning the claims of the ’299 patent at
`
`issue here. Mr. Mandernach is currently counsel for Alcon in litigation against
`
`other generic pharmaceutical companies in the U.S. District Court for the District
`
`of Delaware in which the ’299 patent is at issue: Alcon Research, Ltd. v. Mylan
`
`Pharmaceuticals Inc. & Mylan Inc., No. 1:13-cv-01332 (SLR); Alcon Research,
`
`Ltd. v. Wockhardt Ltd., Wockhardt Bio AG, & Wockhardt USA, LLC, No. 1:13-cv-
`
`02040 (SLR); and Alcon Research, Ltd. v. Micro Labs Ltd. & Micro Labs USA
`
`Inc., No. 1:14-cv-00014 (SLR). In addition, Mr. Mandernach has worked with the
`
`fact and expert witnesses who submitted declarations in connection with Alcon’s
`
`Response to Petitioner’s inter partes petition.
`
`Mr. Mandernach thus has experience litigating the precise subject matter
`
`raised in Petitioner’s inter partes petition. As trial counsel for Alcon, Mr.
`
`Mandernach has been actively involved in all aspects of its district court litigation,
`
`including Alcon’s factual investigation and development concerning the claims of
`
`
`
`6
`
`
`
`Attorney Docket No.
`
`Case IPR2013-00428
`PAT903205-US-NP
`
`U.S. Patent No. 8,268,299
`the ’299 patent being challenged in this proceeding. In view of Mr. Mandernach’s
`
`knowledge of the precise subject matter at issue in this proceeding, and in view of
`
`the interrelatedness of this proceeding and the district court litigation, admission of
`
`Mr. Mandernach pro hac vice will avoid unnecessary expense and duplication of
`
`work for Alcon between this and the district court proceedings identified above.
`
`See 77 Fed. Reg. 48,680, 48,720 (Aug. 14, 2012) (Office’s comment on final rule
`
`discussing concerns about efficiency and costs where a patent owner has already
`
`engaged counsel for parallel district court litigation). In addition, admission of Mr.
`
`Mandernach pro hac vice will enable him to participate in defending the
`
`depositions of the Alcon witnesses with whom he has worked. For these reasons,
`
`Alcon has a substantial need for Mr. Mandernach’s pro hac vice admission and his
`
`involvement in the continued prosecution of this proceeding.
`
`V. CONCLUSION
`
`For the foregoing reasons, Alcon respectfully requests that Mr. Mandernach
`
`be admitted pro hac vice in this proceeding.
`
`The Patent Trial and Appeal Board is hereby authorized to charge any fees
`
`associated with this filing to Deposit Account No. 010682.
`
`
`
`Dated: April 7, 2014
`
`Respectfully submitted,
`
`
`
`/Stanley E. Fisher/
`Stanley E. Fisher
`7
`
`
`
`Attorney Docket No.
`PAT903205-US-NP
`
`
`
`Reg. No. 55,820
`Phone: 202-434-5289
`
`
`Case IPR2013-00428
`U.S. Patent No. 8,268,299
`
`
`Correspondence Address:
`Williams & Connolly LLP
`725 Twelfth Street NW
`Washington, D.C. 20005
`
`
`
`
`
`
`8
`
`
`
`Attorney Docket No.
`
`Case IPR2013-00428
`PAT903205-US-NP
`
`U.S. Patent No. 8,268,299
`CERTIFICATE OF SERVICE (37 C.F.R. § 42.6(e))
`
`The undersigned hereby certifies that the foregoing “ALCON RESEARCH
`
`LTD.’S MOTION FOR PRO HAC VICE ADMISSION OF CHRISTOPHER J.
`
`MANDERNACH PURSUANT TO 37 C.F.R. § 42.10(c)” and “DECLARATION
`
`OF CHRISTOPHER J. MANDERNACH IN SUPPORT OF MOTION FOR PRO
`
`HAC VICE ADMISSION PURSUANT TO 37 C.F.R. § 42.10(c)” were served on
`
`April 7, 2014, by filing this document through the Patent Review Processing
`
`System as well as delivering a copy electronically to the following attorneys of
`
`record for the Petitioner:
`
`Eldora L. Ellison (Reg. No. 39,967)
`Ralph W. Powers III (Reg. No. 63,504)
`David H. Holman (Reg. No. 61,205)
`H. Keeto Sabharwal
`Paul A. Ainsworth
`Sterne, Kessler, Goldstein & Fox P.L.L.C.
`1100 New York Avenue, NW
`Washington, DC 20005
`(202) 371-2600 (telephone)
`(202) 371-2540 (facsimile)
`eellison-PTAB@skgf.com
`tpowers-PTAB@skgf.com
`dholman-PTAB@skgf.com
`keetos-PTAB@skgf.com
`painsworth@skgf.com
`
`
`Dated: April 7, 2014
`
`
`
`
`
`Respectfully submitted,
`
`/Stanley E. Fisher/
`Stanley E. Fisher
`Reg. No. 55,820
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`9
`
`